Visok krvni tlak (Slovenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Visok krvni tlak" in Slovenian language version.

refsWebsite

Global rank Slovenian rank

93nih.gov

4^th place

8^th place

67doi.org

2^nd place

5^th place

11archive.org

6^th place

9^th place

7web.archive.org

1^st place

2^nd place

7ahajournals.org

3,608^th place

1,222^nd place

4nice.org.uk

3,258^th place

1,304^th place

3archive.today

14^th place

46^th place

2medscape.com

719^th place

152^nd place

2who.int

195^th place

64^th place

1chestpubs.org

low place

9,196^th place

1nps.org.au

low place

4,731^st place

1wiley.com

222^nd place

163^rd place

1australianprescriber.com

low place

1hta.ac.uk

low place

1webmd.com

1,169^th place

312^th place

1bnf.org

low place

1aafp.org

1,916^th place

382^nd place

1sagepub.com

731^st place

1,661^st place

aafp.org

Luma GB; Spiotta RT (Maj 2006). »Hypertension in children and adolescents«. Am Fam Physician. 73 (9): 1558–68. PMID 16719248. Arhivirano iz prvotnega spletišča dne 26. septembra 2007. Pridobljeno 16. oktobra 2013.

ahajournals.org

hyper.ahajournals.org

Chobanian AV; Bakris GL; Black HR; in sod. (december 2003). »Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure«. Hypertension. 42 (6): 1206–52. doi:10.1161/01.HYP.0000107251.49515.c2. PMID 14656957.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Zubcevic J; Waki H; Raizada MK; Paton JF (Junij 2011). »Autonomic-immune-vascular interaction: an emerging concept for neurogenic hypertension«. Hypertension. 57 (6): 1026–33. doi:10.1161/HYPERTENSIONAHA.111.169748. PMC 3105900. PMID 21536990.
Sorof J; Daniels S (Oktober 2002). »Obesity hypertension in children: a problem of epidemic proportions«. Hypertension. 40 (4): 441–447. doi:10.1161/01.HYP.0000032940.33466.12. PMID 12364344. Pridobljeno 3. junija 2009.
Okonofua, Eni C.; Simpson, Kit N.; Jesri, Ammar; Rehman, Shakaib U.; Durkalski, Valerie L.; Egan, Brent M. (23. januar 2006). »Therapeutic Inertia Is an Impediment to Achieving the Healthy People 2010 Blood Pressure Control Goals«. Hypertension. 47 (2006, 47:345): 345–51. doi:10.1161/01.HYP.0000200702.76436.4b. PMID 16432045. Pridobljeno 22. novembra 2009.
Burt VL; Whelton P; Roccella EJ; in sod. (Marec 1995). »Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988–1991«. Hypertension. 25 (3): 305–13. doi:10.1161/01.HYP.25.3.305. PMID 7875754. Arhivirano iz prvotnega spletišča dne 5. decembra 2012. Pridobljeno 5. junija 2009.
Burt VL; Cutler JA; Higgins M; in sod. (Julij 1995). »Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991«. Hypertension. 26 (1): 60–9. doi:10.1161/01.HYP.26.1.60. PMID 7607734. Arhivirano iz prvotnega spletišča dne 20. decembra 2012. Pridobljeno 5. junija 2009.

circ.ahajournals.org

Carretero OA; Oparil S (Januar 2000). »Essential hypertension. Part I: definition and etiology«. Circulation. 101 (3): 329–35. doi:10.1161/01.CIR.101.3.329. PMID 10645931.

archive.org

O'Brien, Eoin; Beevers, D.G.; Lip, Gregory Y.H. (2007). ABC of hypertension. London: BMJ Books. ISBN 1-4051-3061-X.
Mesas, AE; Leon-Muñoz, LM; Rodriguez-Artalejo, F; Lopez-Garcia, E (Oktober 2011). »The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: a systematic review and meta-analysis«. The American journal of clinical nutrition. 94 (4): 1113–26. doi:10.3945/ajcn.111.016667. PMID 21880846.
Grossman E; Messerli FH (Januar 2012). »Drug-induced Hypertension: An Unappreciated Cause of Secondary Hypertension«. Am. J. Med. 125 (1): 14–22. doi:10.1016/j.amjmed.2011.05.024. PMID 22195528.
Conway J (april 1984). »Hemodynamic aspects of essential hypertension in humans«. Physiol. Rev. 64 (2): 617–60. PMID 6369352.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Safar ME; London GM (Avgust 1987). »Arterial and venous compliance in sustained essential hypertension«. Hypertension. 10 (2): 133–9. doi:10.1161/01.HYP.10.2.133. PMID 3301662.
Zieman SJ; Melenovsky V; Kass DA (Maj 2005). »Mechanisms, pathophysiology, and therapy of arterial stiffness«. Arterioscler. Thromb. Vasc. Biol. 25 (5): 932–43. doi:10.1161/01.ATV.0000160548.78317.29. PMID 15731494.
Navar LG (december 2010). »Counterpoint: Activation of the intrarenal renin-angiotensin system is the dominant contributor to systemic hypertension«. J. Appl. Physiol. 109 (6): 1998–2000, discussion 2015. doi:10.1152/japplphysiol.00182.2010a. PMC 3006411. PMID 21148349.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Esler M; Lambert E; Schlaich M (december 2010). »Point: Chronic activation of the sympathetic nervous system is the dominant contributor to systemic hypertension«. J. Appl. Physiol. 109 (6): 1996–8, discussion 2016. doi:10.1152/japplphysiol.00182.2010. PMID 20185633.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Calhoun DA; Jones D; Textor S; in sod. (Junij 2008). »Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research«. Hypertension. 51 (6): 1403–19. doi:10.1161/HYPERTENSIONAHA.108.189141. PMID 18391085.
Ostchega Y; Dillon CF; Hughes JP; Carroll M; Yoon S (Julij 2007). »Trends in hypertension prevalence, awareness, treatment, and control in older U.S. adults: data from the National Health and Nutrition Examination Survey 1988 to 2004«. Journal of the American Geriatrics Society. 55 (7): 1056–65. doi:10.1111/j.1532-5415.2007.01215.x. PMID 17608879.
Swales JD, ur. (1995). Manual of hypertension. Oxford: Blackwell Science. str. xiii. ISBN 0-86542-861-1.

archive.today

Burt VL; Whelton P; Roccella EJ; in sod. (Marec 1995). »Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988–1991«. Hypertension. 25 (3): 305–13. doi:10.1161/01.HYP.25.3.305. PMID 7875754. Arhivirano iz prvotnega spletišča dne 5. decembra 2012. Pridobljeno 5. junija 2009.
Burt VL; Cutler JA; Higgins M; in sod. (Julij 1995). »Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991«. Hypertension. 26 (1): 60–9. doi:10.1161/01.HYP.26.1.60. PMID 7607734. Arhivirano iz prvotnega spletišča dne 20. decembra 2012. Pridobljeno 5. junija 2009.
Alcocer L; Cueto L (Junij 2008). »Hypertension, a health economics perspective«. Therapeutic Advances in Cardiovascular Disease. 2 (3): 147–55. doi:10.1177/1753944708090572. PMID 19124418. Arhivirano iz prvotnega spletišča dne 4. decembra 2012. Pridobljeno 20. junija 2009.

australianprescriber.com

Nelson, Mark. »Drug treatment of elevated blood pressure«. Australian Prescriber (33): 108–112. Pridobljeno 11. avgusta 2010.

bnf.org

»2.5.5.1 Angiotensin-converting enzyme inhibitors«. British National Formulary. Zv. No. 62. september 2011. Arhivirano iz prvotnega spletišča dne 23. decembra 2021. Pridobljeno 22. decembra 2011.{{navedi knjigo}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)

chestpubs.org

chestjournal.chestpubs.org

Marik PE; Varon J (Junij 2007). »Hypertensive crises: challenges and management«. Chest. 131 (6): 1949–62. doi:10.1378/chest.06-2490. PMID 17565029.

doi.org

Chobanian AV; Bakris GL; Black HR; in sod. (december 2003). »Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure«. Hypertension. 42 (6): 1206–52. doi:10.1161/01.HYP.0000107251.49515.c2. PMID 14656957.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Carretero OA; Oparil S (Januar 2000). »Essential hypertension. Part I: definition and etiology«. Circulation. 101 (3): 329–35. doi:10.1161/01.CIR.101.3.329. PMID 10645931.
Wong T; Mitchell P (Februar 2007). »The eye in hypertension«. The Lancet. 369 (9559): 425–35. doi:10.1016/S0140-6736(07)60198-6. PMID 17276782.
Zubcevic J; Waki H; Raizada MK; Paton JF (Junij 2011). »Autonomic-immune-vascular interaction: an emerging concept for neurogenic hypertension«. Hypertension. 57 (6): 1026–33. doi:10.1161/HYPERTENSIONAHA.111.169748. PMC 3105900. PMID 21536990.
Papadopoulos DP; Mourouzis I; Thomopoulos C; Makris T; Papademetriou V (december 2010). »Hypertension crisis«. Blood Press. 19 (6): 328–36. doi:10.3109/08037051.2010.488052. PMID 20504242.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Marik PE; Varon J (Junij 2007). »Hypertensive crises: challenges and management«. Chest. 131 (6): 1949–62. doi:10.1378/chest.06-2490. PMID 17565029.
Dionne JM; Abitbol CL; Flynn JT (Januar 2012). »Hypertension in infancy: diagnosis, management and outcome«. Pediatr. Nephrol. 27 (1): 17–32. doi:10.1007/s00467-010-1755-z. PMID 21258818.
Vasan, RS; Beiser, A; Seshadri, S; Larson, MG; Kannel, WB; D'Agostino, RB; Levy, D (27. februar 2002). »Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study«. JAMA: the Journal of the American Medical Association. 287 (8): 1003–10. doi:10.1001/jama.287.8.1003. PMID 11866648.
Ehret GB; Munroe PB; Rice KM; in sod. (Oktober 2011). »Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk«. Nature. 478 (7367): 103–9. doi:10.1038/nature10405. PMC 3340926. PMID 21909115.
Lifton, RP; Gharavi, AG; Geller, DS (23. februar 2001). »Molecular mechanisms of human hypertension«. Cell. 104 (4): 545–56. doi:10.1016/S0092-8674(01)00241-0. PMID 11239411.
He, FJ; MacGregor, GA (Junij 2009). »A comprehensive review on salt and health and current experience of worldwide salt reduction programmes«. Journal of Human Hypertension. 23 (6): 363–84. doi:10.1038/jhh.2008.144. PMID 19110538.
Dickinson HO; Mason JM; Nicolson DJ; in sod. (Februar 2006). »Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials«. J. Hypertens. 24 (2): 215–33. doi:10.1097/01.hjh.0000199800.72563.26. PMID 16508562.
Haslam DW; James WP (2005). »Obesity«. Lancet. 366 (9492): 1197–209. doi:10.1016/S0140-6736(05)67483-1. PMID 16198769.
Whelton PK; He J; Appel LJ; Cutler JA; Havas S; Kotchen TA; in sod. (2002). »Primary prevention of hypertension:Clinical and public health advisory from The National High Blood Pressure Education Program«. JAMA. 288 (15): 1882–8. doi:10.1001/jama.288.15.1882. PMID 12377087.
Dickinson, HO; Mason, JM; Nicolson, DJ; Campbell, F; Beyer, FR; Cook, JV; Williams; B; Ford, GA (Februar 2006). »Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials«. Journal of hypertension. 24 (2): 215–233. doi:10.1097/01.hjh.0000199800.72563.26. PMID 16508562.{{navedi časopis}}: Vzdrževanje CS1: več imen: seznam avtorjev (povezava)
Mesas, AE; Leon-Muñoz, LM; Rodriguez-Artalejo, F; Lopez-Garcia, E (Oktober 2011). »The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: a systematic review and meta-analysis«. The American journal of clinical nutrition. 94 (4): 1113–26. doi:10.3945/ajcn.111.016667. PMID 21880846.
Vaidya A; Forman JP (november 2010). »Vitamin D and hypertension: current evidence and future directions«. Hypertension. 56 (5): 774–9. doi:10.1161/HYPERTENSIONAHA.109.140160. PMID 20937970.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Sorof J; Daniels S (Oktober 2002). »Obesity hypertension in children: a problem of epidemic proportions«. Hypertension. 40 (4): 441–447. doi:10.1161/01.HYP.0000032940.33466.12. PMID 12364344. Pridobljeno 3. junija 2009.
Lawlor, DA; Smith, GD (Maj 2005). »Early life determinants of adult blood pressure«. Current opinion in nephrology and hypertension. 14 (3): 259–64. doi:10.1097/01.mnh.0000165893.13620.2b. PMID 15821420.
Grossman E; Messerli FH (Januar 2012). »Drug-induced Hypertension: An Unappreciated Cause of Secondary Hypertension«. Am. J. Med. 125 (1): 14–22. doi:10.1016/j.amjmed.2011.05.024. PMID 22195528.
Palatini P; Julius S (Junij 2009). »The role of cardiac autonomic function in hypertension and cardiovascular disease«. Curr. Hypertens. Rep. 11 (3): 199–205. doi:10.1007/s11906-009-0035-4. PMID 19442329.
Andersson OK; Lingman M; Himmelmann A; Sivertsson R; Widgren BR (2004). »Prediction of future hypertension by casual blood pressure or invasive hemodynamics? A 30-year follow-up study«. Blood Press. 13 (6): 350–4. doi:10.1080/08037050410004819. PMID 15771219.
Safar ME; London GM (Avgust 1987). »Arterial and venous compliance in sustained essential hypertension«. Hypertension. 10 (2): 133–9. doi:10.1161/01.HYP.10.2.133. PMID 3301662.
Chobanian AV (Avgust 2007). »Clinical practice. Isolated systolic hypertension in the elderly«. N. Engl. J. Med. 357 (8): 789–96. doi:10.1056/NEJMcp071137. PMID 17715411.
Zieman SJ; Melenovsky V; Kass DA (Maj 2005). »Mechanisms, pathophysiology, and therapy of arterial stiffness«. Arterioscler. Thromb. Vasc. Biol. 25 (5): 932–43. doi:10.1161/01.ATV.0000160548.78317.29. PMID 15731494.
Navar LG (december 2010). »Counterpoint: Activation of the intrarenal renin-angiotensin system is the dominant contributor to systemic hypertension«. J. Appl. Physiol. 109 (6): 1998–2000, discussion 2015. doi:10.1152/japplphysiol.00182.2010a. PMC 3006411. PMID 21148349.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Esler M; Lambert E; Schlaich M (december 2010). »Point: Chronic activation of the sympathetic nervous system is the dominant contributor to systemic hypertension«. J. Appl. Physiol. 109 (6): 1996–8, discussion 2016. doi:10.1152/japplphysiol.00182.2010. PMID 20185633.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Versari D; Daghini E; Virdis A; Ghiadoni L; Taddei S (Junij 2009). »Endothelium-dependent contractions and endothelial dysfunction in human hypertension«. Br. J. Pharmacol. 157 (4): 527–36. doi:10.1111/j.1476-5381.2009.00240.x. PMC 2707964. PMID 19630832.
Marchesi C; Paradis P; Schiffrin EL (Julij 2008). »Role of the renin-angiotensin system in vascular inflammation«. Trends Pharmacol. Sci. 29 (7): 367–74. doi:10.1016/j.tips.2008.05.003. PMID 18579222.
Padwal RS; Hemmelgarn BR; Khan NA; in sod. (Maj 2009). »The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 – blood pressure measurement, diagnosis and assessment of risk«. Canadian Journal of Cardiology. 25 (5): 279–86. doi:10.1016/S0828-282X(09)70491-X. PMC 2707176. PMID 19417858.
Padwal RJ; Hemmelgarn BR; Khan NA; in sod. (Junij 2008). »The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 – blood pressure measurement, diagnosis and assessment of risk«. Canadian Journal of Cardiology. 24 (6): 455–63. doi:10.1016/S0828-282X(08)70619-6. PMC 2643189. PMID 18548142.
Padwal RS; Hemmelgarn BR; McAlister FA; in sod. (Maj 2007). »The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 – blood pressure measurement, diagnosis and assessment of risk«. Canadian Journal of Cardiology. 23 (7): 529–38. doi:10.1016/S0828-282X(07)70797-3. PMC 2650756. PMID 17534459.
Hemmelgarn BR; McAlister FA; Grover S; in sod. (Maj 2006). »The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I – Blood pressure measurement, diagnosis and assessment of risk«. Canadian Journal of Cardiology. 22 (7): 573–81. doi:10.1016/S0828-282X(06)70279-3. PMC 2560864. PMID 16755312.
Franklin, SS; Wilkinson, IB; McEniery, CM (Februar 2012). »Unusual hypertensive phenotypes: what is their significance?«. Hypertension. 59 (2): 173–8. doi:10.1161/HYPERTENSIONAHA.111.182956. PMID 22184330.
Mancia G; De Backer G; Dominiczak A; in sod. (september 2007). »2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension«. J. Hypertens. 25 (9): 1751–62. doi:10.1097/HJH.0b013e3282f0580f. PMID 17762635.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Williams, B; Poulter, NR; Brown, MJ; Davis, M; McInnes, GT; Potter, JF; Sever, PS; McG Thom, S; British Hypertension Society (Marec 2004). »Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV«. Journal of Human Hypertension. 18 (3): 139–85. doi:10.1038/sj.jhh.1001683. PMID 14973512.
Din-Dzietham R; Liu Y; Bielo MV; Shamsa F (september 2007). »High blood pressure trends in children and adolescents in national surveys, 1963 to 2002«. Circulation. 116 (13): 1488–96. doi:10.1161/CIRCULATIONAHA.106.683243. PMID 17846287.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (Avgust 2004). »The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents«. Pediatrics. 114 (2 Suppl 4th Report): 555–76. doi:10.1542/peds.114.2.S2.555. PMID 15286277.
Whelton PK; in sod. (2002). »Primary prevention of hypertension. Clinical and public health advisory from the National High Blood Pressure Education Program«. JAMA. 288 (15): 1882–1888. doi:10.1001/jama.288.15.1882. PMID 12377087.
Siebenhofer, A; Jeitler, K; Berghold, A; Waltering, A; Hemkens, LG; Semlitsch, T; Pachler, C; Strametz, R; Horvath, K (7. september 2011). Siebenhofer, Andrea (ur.). »Long-term effects of weight-reducing diets in hypertensive patients«. Cochrane database of systematic reviews (Online). 9 (9): CD008274. doi:10.1002/14651858.CD008274.pub2. PMID 21901719.
Blumenthal JA; Babyak MA; Hinderliter A; in sod. (Januar 2010). »Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study«. Arch. Intern. Med. 170 (2): 126–35. doi:10.1001/archinternmed.2009.470. PMID 20101007.
He, FJ; MacGregor, GA (2004). MacGregor, Graham A (ur.). »Effect of longer-term modest salt reduction on blood pressure«. Cochrane database of systematic reviews (Online) (3): CD004937. doi:10.1002/14651858.CD004937. PMID 15266549.
Diao, Diana (2012). »Pharmacotherapy for mild hypertension«. The Cochrane Collaboration (8). doi:10.1002/14651858.CD006742.pub2.
Okonofua, Eni C.; Simpson, Kit N.; Jesri, Ammar; Rehman, Shakaib U.; Durkalski, Valerie L.; Egan, Brent M. (23. januar 2006). »Therapeutic Inertia Is an Impediment to Achieving the Healthy People 2010 Blood Pressure Control Goals«. Hypertension. 47 (2006, 47:345): 345–51. doi:10.1161/01.HYP.0000200702.76436.4b. PMID 16432045. Pridobljeno 22. novembra 2009.
Klarenbach, SW; McAlister, FA; Johansen, H; Tu, K; Hazel, M; Walker, R; Zarnke, KB; Campbell, NR; Canadian Hypertension Education Program (Maj 2010). »Identification of factors driving differences in cost effectiveness of first-line pharmacological therapy for uncomplicated hypertension«. The Canadian journal of cardiology. 26 (5): e158–63. doi:10.1016/S0828-282X(10)70383-4. PMC 2886561. PMID 20485695.
Wright JM; Musini VM (2009). Wright, James M (ur.). »First-line drugs for hypertension«. Cochrane Database Syst Rev (3): CD001841. doi:10.1002/14651858.CD001841.pub2. PMID 19588327.
Sever PS; Messerli FH (Oktober 2011). »Hypertension management 2011: optimal combination therapy«. Eur. Heart J. 32 (20): 2499–506. doi:10.1093/eurheartj/ehr177. PMID 21697169.
Musini VM; Tejani AM; Bassett K; Wright JM (2009). Musini, Vijaya M (ur.). »Pharmacotherapy for hypertension in the elderly«. Cochrane Database Syst Rev (4): CD000028. doi:10.1002/14651858.CD000028.pub2. PMID 19821263.
Aronow WS; Fleg JL; Pepine CJ; in sod. (Maj 2011). »ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension«. J. Am. Coll. Cardiol. 57 (20): 2037–114. doi:10.1016/j.jacc.2011.01.008. PMID 21524875.
Calhoun DA; Jones D; Textor S; in sod. (Junij 2008). »Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research«. Hypertension. 51 (6): 1403–19. doi:10.1161/HYPERTENSIONAHA.108.189141. PMID 18391085.
Kearney PM; Whelton M; Reynolds K; Muntner P; Whelton PK; He J (2005). »Global burden of hypertension: analysis of worldwide data«. The Lancet. 365 (9455): 217–23. doi:10.1016/S0140-6736(05)17741-1. PMID 15652604.
Kearney PM; Whelton M; Reynolds K; Whelton PK; He J (Januar 2004). »Worldwide prevalence of hypertension: a systematic review«. J. Hypertens. 22 (1): 11–9. doi:10.1097/00004872-200401000-00003. PMID 15106785.
Burt VL; Whelton P; Roccella EJ; in sod. (Marec 1995). »Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988–1991«. Hypertension. 25 (3): 305–13. doi:10.1161/01.HYP.25.3.305. PMID 7875754. Arhivirano iz prvotnega spletišča dne 5. decembra 2012. Pridobljeno 5. junija 2009.
Burt VL; Cutler JA; Higgins M; in sod. (Julij 1995). »Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991«. Hypertension. 26 (1): 60–9. doi:10.1161/01.HYP.26.1.60. PMID 7607734. Arhivirano iz prvotnega spletišča dne 20. decembra 2012. Pridobljeno 5. junija 2009.
Ostchega Y; Dillon CF; Hughes JP; Carroll M; Yoon S (Julij 2007). »Trends in hypertension prevalence, awareness, treatment, and control in older U.S. adults: data from the National Health and Nutrition Examination Survey 1988 to 2004«. Journal of the American Geriatrics Society. 55 (7): 1056–65. doi:10.1111/j.1532-5415.2007.01215.x. PMID 17608879.
Lloyd-Jones D; Adams RJ; Brown TM; in sod. (Februar 2010). »Heart disease and stroke statistics--2010 update: a report from the American Heart Association«. Circulation. 121 (7): e46–e215. doi:10.1161/CIRCULATIONAHA.109.192667. PMID 20019324.
Falkner B (Maj 2009). »Hypertension in children and adolescents: epidemiology and natural history«. Pediatr. Nephrol. 25 (7): 1219–24. doi:10.1007/s00467-009-1200-3. PMC 2874036. PMID 19421783.
Lewington S; Clarke R; Qizilbash N; Peto R; Collins R (december 2002). »Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies«. Lancet. 360 (9349): 1903–13. doi:10.1016/S0140-6736(02)11911-8. PMID 12493255.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Singer DR; Kite A (Junij 2008). »Management of hypertension in peripheral arterial disease: does the choice of drugs matter?«. European Journal of Vascular and Endovascular Surgery. 35 (6): 701–8. doi:10.1016/j.ejvs.2008.01.007. PMID 18375152.
Kotchen TA (Oktober 2011). »Historical trends and milestones in hypertension research: a model of the process of translational research«. Hypertension. 58 (4): 522–38. doi:10.1161/HYPERTENSIONAHA.111.177766. PMID 21859967.
Dustan HP; Roccella EJ; Garrison HH (september 1996). »Controlling hypertension. A research success story«. Arch. Intern. Med. 156 (17): 1926–35. doi:10.1001/archinte.156.17.1926. PMID 8823146.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Novello FC; Sprague JM (1957). »Benzothiadiazine dioxides as novel diuretics«. J. Am. Chem. Soc. 79 (8): 2028. doi:10.1021/ja01565a079.
Chockalingam A (Maj 2007). »Impact of World Hypertension Day«. Canadian Journal of Cardiology. 23 (7): 517–9. doi:10.1016/S0828-282X(07)70795-X. PMC 2650754. PMID 17534457.
Chockalingam A (Junij 2008). »World Hypertension Day and global awareness«. Canadian Journal of Cardiology. 24 (6): 441–4. doi:10.1016/S0828-282X(08)70617-2. PMC 2643187. PMID 18548140.
Alcocer L; Cueto L (Junij 2008). »Hypertension, a health economics perspective«. Therapeutic Advances in Cardiovascular Disease. 2 (3): 147–55. doi:10.1177/1753944708090572. PMID 19124418. Arhivirano iz prvotnega spletišča dne 4. decembra 2012. Pridobljeno 20. junija 2009.
William J. Elliott (Oktober 2003). »The Economic Impact of Hypertension«. The Journal of Clinical Hypertension. 5 (4): 3–13. doi:10.1111/j.1524-6175.2003.02463.x. PMID 12826765.
Coca A (2008). »Economic benefits of treating high-risk hypertension with angiotensin II receptor antagonists (blockers)«. Clinical Drug Investigation. 28 (4): 211–20. doi:10.2165/00044011-200828040-00002. PMID 18345711.

hta.ac.uk

Law M; Wald N; Morris J (2003). »Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy« (PDF). Health Technol Assess. 7 (31): 1–94. PMID 14604498. Arhivirano iz prvotnega spletišča (PDF) dne 4. marca 2011. Pridobljeno 16. oktobra 2013.

medscape.com

emedicine.medscape.com

Gibson, Paul (30. julij 2009). »Hypertension and Pregnancy«. eMedicine Obstetrics and Gynecology. Medscape. Pridobljeno 16. junija 2009.
Rodriguez-Cruz, Edwin; Ettinger, Leigh M. (6. april 2010). »Hypertension«. eMedicine Pediatrics: Cardiac Disease and Critical Care Medicine. Medscape. Pridobljeno 16. junija 2009.

nice.org.uk

National Clinical Guideline Centre (Avgust 2011). »7 Diagnosis of Hypertension, 7.5 Link from evidence to recommendations«. Hypertension (NICE CG 127) (PDF). National Institute for Health and Clinical Excellence. str. 102. Arhivirano iz prvotnega spletišča (PDF) dne 23. julija 2013. Pridobljeno 22. decembra 2011.
»CG34 Hypertension - quick reference guide« (PDF). National Institute for Health and Clinical Excellence. 28. junij 2006. Arhivirano iz prvotnega spletišča (PDF) dne 13. marca 2009. Pridobljeno 4. marca 2009.

guidance.nice.org.uk

North of England Hypertension Guideline Development Group (1. avgust 2004). »Frequency of measurements«. Essential hypertension (NICE CG18). National Institute for Health and Clinical Excellence. str. 53. Arhivirano iz prvotnega spletišča dne 14. julija 2012. Pridobljeno 22. decembra 2011.

publications.nice.org.uk

National Institute Clinical Excellence (Avgust 2011). »1.5 Initiating and monitoring antihypertensive drug treatment, including blood pressure targets«. GC127 Hypertension: Clinical management of primary hypertension in adults. Arhivirano iz prvotnega spletišča dne 15. maja 2013. Pridobljeno 23. decembra 2011.

nih.gov

pubmed.ncbi.nlm.nih.gov

Chobanian AV; Bakris GL; Black HR; in sod. (december 2003). »Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure«. Hypertension. 42 (6): 1206–52. doi:10.1161/01.HYP.0000107251.49515.c2. PMID 14656957.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Carretero OA; Oparil S (Januar 2000). »Essential hypertension. Part I: definition and etiology«. Circulation. 101 (3): 329–35. doi:10.1161/01.CIR.101.3.329. PMID 10645931.
Wong T; Mitchell P (Februar 2007). »The eye in hypertension«. The Lancet. 369 (9559): 425–35. doi:10.1016/S0140-6736(07)60198-6. PMID 17276782.
Zubcevic J; Waki H; Raizada MK; Paton JF (Junij 2011). »Autonomic-immune-vascular interaction: an emerging concept for neurogenic hypertension«. Hypertension. 57 (6): 1026–33. doi:10.1161/HYPERTENSIONAHA.111.169748. PMC 3105900. PMID 21536990.
Papadopoulos DP; Mourouzis I; Thomopoulos C; Makris T; Papademetriou V (december 2010). »Hypertension crisis«. Blood Press. 19 (6): 328–36. doi:10.3109/08037051.2010.488052. PMID 20504242.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Marik PE; Varon J (Junij 2007). »Hypertensive crises: challenges and management«. Chest. 131 (6): 1949–62. doi:10.1378/chest.06-2490. PMID 17565029.
Dionne JM; Abitbol CL; Flynn JT (Januar 2012). »Hypertension in infancy: diagnosis, management and outcome«. Pediatr. Nephrol. 27 (1): 17–32. doi:10.1007/s00467-010-1755-z. PMID 21258818.
Vasan, RS; Beiser, A; Seshadri, S; Larson, MG; Kannel, WB; D'Agostino, RB; Levy, D (27. februar 2002). »Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study«. JAMA: the Journal of the American Medical Association. 287 (8): 1003–10. doi:10.1001/jama.287.8.1003. PMID 11866648.
Ehret GB; Munroe PB; Rice KM; in sod. (Oktober 2011). »Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk«. Nature. 478 (7367): 103–9. doi:10.1038/nature10405. PMC 3340926. PMID 21909115.
Lifton, RP; Gharavi, AG; Geller, DS (23. februar 2001). »Molecular mechanisms of human hypertension«. Cell. 104 (4): 545–56. doi:10.1016/S0092-8674(01)00241-0. PMID 11239411.
He, FJ; MacGregor, GA (Junij 2009). »A comprehensive review on salt and health and current experience of worldwide salt reduction programmes«. Journal of Human Hypertension. 23 (6): 363–84. doi:10.1038/jhh.2008.144. PMID 19110538.
Dickinson HO; Mason JM; Nicolson DJ; in sod. (Februar 2006). »Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials«. J. Hypertens. 24 (2): 215–33. doi:10.1097/01.hjh.0000199800.72563.26. PMID 16508562.
Haslam DW; James WP (2005). »Obesity«. Lancet. 366 (9492): 1197–209. doi:10.1016/S0140-6736(05)67483-1. PMID 16198769.
Whelton PK; He J; Appel LJ; Cutler JA; Havas S; Kotchen TA; in sod. (2002). »Primary prevention of hypertension:Clinical and public health advisory from The National High Blood Pressure Education Program«. JAMA. 288 (15): 1882–8. doi:10.1001/jama.288.15.1882. PMID 12377087.
Marshall, IJ; Wolfe, CD; McKevitt, C (9. julij 2012). »Lay perspectives on hypertension and drug adherence: systematic review of qualitative research«. BMJ (Clinical research ed.). 345: e3953. PMC 3392078. PMID 22777025.
Dickinson, HO; Mason, JM; Nicolson, DJ; Campbell, F; Beyer, FR; Cook, JV; Williams; B; Ford, GA (Februar 2006). »Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials«. Journal of hypertension. 24 (2): 215–233. doi:10.1097/01.hjh.0000199800.72563.26. PMID 16508562.{{navedi časopis}}: Vzdrževanje CS1: več imen: seznam avtorjev (povezava)
Ospina MB; Bond K; Karkhaneh M; in sod. (Junij 2007). »Meditation practices for health: state of the research«. Evid Rep Technol Assess (Full Rep) (155): 1–263. PMID 17764203.
Mesas, AE; Leon-Muñoz, LM; Rodriguez-Artalejo, F; Lopez-Garcia, E (Oktober 2011). »The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: a systematic review and meta-analysis«. The American journal of clinical nutrition. 94 (4): 1113–26. doi:10.3945/ajcn.111.016667. PMID 21880846.
Vaidya A; Forman JP (november 2010). »Vitamin D and hypertension: current evidence and future directions«. Hypertension. 56 (5): 774–9. doi:10.1161/HYPERTENSIONAHA.109.140160. PMID 20937970.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Sorof J; Daniels S (Oktober 2002). »Obesity hypertension in children: a problem of epidemic proportions«. Hypertension. 40 (4): 441–447. doi:10.1161/01.HYP.0000032940.33466.12. PMID 12364344. Pridobljeno 3. junija 2009.
Lawlor, DA; Smith, GD (Maj 2005). »Early life determinants of adult blood pressure«. Current opinion in nephrology and hypertension. 14 (3): 259–64. doi:10.1097/01.mnh.0000165893.13620.2b. PMID 15821420.
Grossman E; Messerli FH (Januar 2012). »Drug-induced Hypertension: An Unappreciated Cause of Secondary Hypertension«. Am. J. Med. 125 (1): 14–22. doi:10.1016/j.amjmed.2011.05.024. PMID 22195528.
Conway J (april 1984). »Hemodynamic aspects of essential hypertension in humans«. Physiol. Rev. 64 (2): 617–60. PMID 6369352.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Palatini P; Julius S (Junij 2009). »The role of cardiac autonomic function in hypertension and cardiovascular disease«. Curr. Hypertens. Rep. 11 (3): 199–205. doi:10.1007/s11906-009-0035-4. PMID 19442329.
Andersson OK; Lingman M; Himmelmann A; Sivertsson R; Widgren BR (2004). »Prediction of future hypertension by casual blood pressure or invasive hemodynamics? A 30-year follow-up study«. Blood Press. 13 (6): 350–4. doi:10.1080/08037050410004819. PMID 15771219.
Folkow B (april 1982). »Physiological aspects of primary hypertension«. Physiol. Rev. Rev. 62 (2): 347–504. PMID 6461865.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Struijker Boudier HA; le Noble JL; Messing MW; Huijberts MS; le Noble FA; van Essen H (december 1992). »The microcirculation and hypertension«. J Hypertens Suppl. 10 (7): S147–56. PMID 1291649.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Safar ME; London GM (Avgust 1987). »Arterial and venous compliance in sustained essential hypertension«. Hypertension. 10 (2): 133–9. doi:10.1161/01.HYP.10.2.133. PMID 3301662.
Schiffrin EL (Februar 1992). »Reactivity of small blood vessels in hypertension: relation with structural changes. State of the art lecture«. Hypertension. 19 (2 Suppl): II1–9. PMID 1735561.
Chobanian AV (Avgust 2007). »Clinical practice. Isolated systolic hypertension in the elderly«. N. Engl. J. Med. 357 (8): 789–96. doi:10.1056/NEJMcp071137. PMID 17715411.
Zieman SJ; Melenovsky V; Kass DA (Maj 2005). »Mechanisms, pathophysiology, and therapy of arterial stiffness«. Arterioscler. Thromb. Vasc. Biol. 25 (5): 932–43. doi:10.1161/01.ATV.0000160548.78317.29. PMID 15731494.
Navar LG (december 2010). »Counterpoint: Activation of the intrarenal renin-angiotensin system is the dominant contributor to systemic hypertension«. J. Appl. Physiol. 109 (6): 1998–2000, discussion 2015. doi:10.1152/japplphysiol.00182.2010a. PMC 3006411. PMID 21148349.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Esler M; Lambert E; Schlaich M (december 2010). »Point: Chronic activation of the sympathetic nervous system is the dominant contributor to systemic hypertension«. J. Appl. Physiol. 109 (6): 1996–8, discussion 2016. doi:10.1152/japplphysiol.00182.2010. PMID 20185633.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Versari D; Daghini E; Virdis A; Ghiadoni L; Taddei S (Junij 2009). »Endothelium-dependent contractions and endothelial dysfunction in human hypertension«. Br. J. Pharmacol. 157 (4): 527–36. doi:10.1111/j.1476-5381.2009.00240.x. PMC 2707964. PMID 19630832.
Marchesi C; Paradis P; Schiffrin EL (Julij 2008). »Role of the renin-angiotensin system in vascular inflammation«. Trends Pharmacol. Sci. 29 (7): 367–74. doi:10.1016/j.tips.2008.05.003. PMID 18579222.
Padwal RS; Hemmelgarn BR; Khan NA; in sod. (Maj 2009). »The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 – blood pressure measurement, diagnosis and assessment of risk«. Canadian Journal of Cardiology. 25 (5): 279–86. doi:10.1016/S0828-282X(09)70491-X. PMC 2707176. PMID 19417858.
Padwal RJ; Hemmelgarn BR; Khan NA; in sod. (Junij 2008). »The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 – blood pressure measurement, diagnosis and assessment of risk«. Canadian Journal of Cardiology. 24 (6): 455–63. doi:10.1016/S0828-282X(08)70619-6. PMC 2643189. PMID 18548142.
Padwal RS; Hemmelgarn BR; McAlister FA; in sod. (Maj 2007). »The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 – blood pressure measurement, diagnosis and assessment of risk«. Canadian Journal of Cardiology. 23 (7): 529–38. doi:10.1016/S0828-282X(07)70797-3. PMC 2650756. PMID 17534459.
Hemmelgarn BR; McAlister FA; Grover S; in sod. (Maj 2006). »The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I – Blood pressure measurement, diagnosis and assessment of risk«. Canadian Journal of Cardiology. 22 (7): 573–81. doi:10.1016/S0828-282X(06)70279-3. PMC 2560864. PMID 16755312.
Hemmelgarn BR; McAllister FA; Myers MG; in sod. (Junij 2005). »The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of risk«. Canadian Journal of Cardiology. 21 (8): 645–56. PMID 16003448.
Franklin, SS; Wilkinson, IB; McEniery, CM (Februar 2012). »Unusual hypertensive phenotypes: what is their significance?«. Hypertension. 59 (2): 173–8. doi:10.1161/HYPERTENSIONAHA.111.182956. PMID 22184330.
Luma GB; Spiotta RT (Maj 2006). »Hypertension in children and adolescents«. Am Fam Physician. 73 (9): 1558–68. PMID 16719248.
Giuseppe, Mancia (Julij 2013). »2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)«. European heart journal. 34 (28): 2159–219. PMID 23771844.
Mancia G; De Backer G; Dominiczak A; in sod. (september 2007). »2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension«. J. Hypertens. 25 (9): 1751–62. doi:10.1097/HJH.0b013e3282f0580f. PMID 17762635.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Williams, B; Poulter, NR; Brown, MJ; Davis, M; McInnes, GT; Potter, JF; Sever, PS; McG Thom, S; British Hypertension Society (Marec 2004). »Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV«. Journal of Human Hypertension. 18 (3): 139–85. doi:10.1038/sj.jhh.1001683. PMID 14973512.
Din-Dzietham R; Liu Y; Bielo MV; Shamsa F (september 2007). »High blood pressure trends in children and adolescents in national surveys, 1963 to 2002«. Circulation. 116 (13): 1488–96. doi:10.1161/CIRCULATIONAHA.106.683243. PMID 17846287.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (Avgust 2004). »The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents«. Pediatrics. 114 (2 Suppl 4th Report): 555–76. doi:10.1542/peds.114.2.S2.555. PMID 15286277.
Whelton PK; in sod. (2002). »Primary prevention of hypertension. Clinical and public health advisory from the National High Blood Pressure Education Program«. JAMA. 288 (15): 1882–1888. doi:10.1001/jama.288.15.1882. PMID 12377087.
Siebenhofer, A; Jeitler, K; Berghold, A; Waltering, A; Hemkens, LG; Semlitsch, T; Pachler, C; Strametz, R; Horvath, K (7. september 2011). Siebenhofer, Andrea (ur.). »Long-term effects of weight-reducing diets in hypertensive patients«. Cochrane database of systematic reviews (Online). 9 (9): CD008274. doi:10.1002/14651858.CD008274.pub2. PMID 21901719.
Blumenthal JA; Babyak MA; Hinderliter A; in sod. (Januar 2010). »Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study«. Arch. Intern. Med. 170 (2): 126–35. doi:10.1001/archinternmed.2009.470. PMID 20101007.
He, FJ; MacGregor, GA (2004). MacGregor, Graham A (ur.). »Effect of longer-term modest salt reduction on blood pressure«. Cochrane database of systematic reviews (Online) (3): CD004937. doi:10.1002/14651858.CD004937. PMID 15266549.
Greenhalgh J; Dickson R; Dundar Y (Oktober 2009). »The effects of biofeedback for the treatment of essential hypertension: a systematic review«. Health Technol Assess. 13 (46): 1–104. PMID 19822104.
Law M; Wald N; Morris J (2003). »Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy« (PDF). Health Technol Assess. 7 (31): 1–94. PMID 14604498. Arhivirano iz prvotnega spletišča (PDF) dne 4. marca 2011. Pridobljeno 16. oktobra 2013.
Okonofua, Eni C.; Simpson, Kit N.; Jesri, Ammar; Rehman, Shakaib U.; Durkalski, Valerie L.; Egan, Brent M. (23. januar 2006). »Therapeutic Inertia Is an Impediment to Achieving the Healthy People 2010 Blood Pressure Control Goals«. Hypertension. 47 (2006, 47:345): 345–51. doi:10.1161/01.HYP.0000200702.76436.4b. PMID 16432045. Pridobljeno 22. novembra 2009.
Klarenbach, SW; McAlister, FA; Johansen, H; Tu, K; Hazel, M; Walker, R; Zarnke, KB; Campbell, NR; Canadian Hypertension Education Program (Maj 2010). »Identification of factors driving differences in cost effectiveness of first-line pharmacological therapy for uncomplicated hypertension«. The Canadian journal of cardiology. 26 (5): e158–63. doi:10.1016/S0828-282X(10)70383-4. PMC 2886561. PMID 20485695.
Wright JM; Musini VM (2009). Wright, James M (ur.). »First-line drugs for hypertension«. Cochrane Database Syst Rev (3): CD001841. doi:10.1002/14651858.CD001841.pub2. PMID 19588327.
Sever PS; Messerli FH (Oktober 2011). »Hypertension management 2011: optimal combination therapy«. Eur. Heart J. 32 (20): 2499–506. doi:10.1093/eurheartj/ehr177. PMID 21697169.
Musini VM; Tejani AM; Bassett K; Wright JM (2009). Musini, Vijaya M (ur.). »Pharmacotherapy for hypertension in the elderly«. Cochrane Database Syst Rev (4): CD000028. doi:10.1002/14651858.CD000028.pub2. PMID 19821263.
Aronow WS; Fleg JL; Pepine CJ; in sod. (Maj 2011). »ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension«. J. Am. Coll. Cardiol. 57 (20): 2037–114. doi:10.1016/j.jacc.2011.01.008. PMID 21524875.
Calhoun DA; Jones D; Textor S; in sod. (Junij 2008). »Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research«. Hypertension. 51 (6): 1403–19. doi:10.1161/HYPERTENSIONAHA.108.189141. PMID 18391085.
Kearney PM; Whelton M; Reynolds K; Muntner P; Whelton PK; He J (2005). »Global burden of hypertension: analysis of worldwide data«. The Lancet. 365 (9455): 217–23. doi:10.1016/S0140-6736(05)17741-1. PMID 15652604.
Kearney PM; Whelton M; Reynolds K; Whelton PK; He J (Januar 2004). »Worldwide prevalence of hypertension: a systematic review«. J. Hypertens. 22 (1): 11–9. doi:10.1097/00004872-200401000-00003. PMID 15106785.
Burt VL; Whelton P; Roccella EJ; in sod. (Marec 1995). »Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988–1991«. Hypertension. 25 (3): 305–13. doi:10.1161/01.HYP.25.3.305. PMID 7875754. Arhivirano iz prvotnega spletišča dne 5. decembra 2012. Pridobljeno 5. junija 2009.
Burt VL; Cutler JA; Higgins M; in sod. (Julij 1995). »Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991«. Hypertension. 26 (1): 60–9. doi:10.1161/01.HYP.26.1.60. PMID 7607734. Arhivirano iz prvotnega spletišča dne 20. decembra 2012. Pridobljeno 5. junija 2009.
Ostchega Y; Dillon CF; Hughes JP; Carroll M; Yoon S (Julij 2007). »Trends in hypertension prevalence, awareness, treatment, and control in older U.S. adults: data from the National Health and Nutrition Examination Survey 1988 to 2004«. Journal of the American Geriatrics Society. 55 (7): 1056–65. doi:10.1111/j.1532-5415.2007.01215.x. PMID 17608879.
Lloyd-Jones D; Adams RJ; Brown TM; in sod. (Februar 2010). »Heart disease and stroke statistics--2010 update: a report from the American Heart Association«. Circulation. 121 (7): e46–e215. doi:10.1161/CIRCULATIONAHA.109.192667. PMID 20019324.
Falkner B (Maj 2009). »Hypertension in children and adolescents: epidemiology and natural history«. Pediatr. Nephrol. 25 (7): 1219–24. doi:10.1007/s00467-009-1200-3. PMC 2874036. PMID 19421783.
Luma GB; Spiotta RT (Maj 2006). »Hypertension in children and adolescents«. Am Fam Physician. 73 (9): 1558–68. PMID 16719248. Arhivirano iz prvotnega spletišča dne 26. septembra 2007. Pridobljeno 16. oktobra 2013.
Lewington S; Clarke R; Qizilbash N; Peto R; Collins R (december 2002). »Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies«. Lancet. 360 (9349): 1903–13. doi:10.1016/S0140-6736(02)11911-8. PMID 12493255.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Singer DR; Kite A (Junij 2008). »Management of hypertension in peripheral arterial disease: does the choice of drugs matter?«. European Journal of Vascular and Endovascular Surgery. 35 (6): 701–8. doi:10.1016/j.ejvs.2008.01.007. PMID 18375152.
Esunge PM (Oktober 1991). »From blood pressure to hypertension: the history of research«. J R Soc Med. 84 (10): 621. PMC 1295564. PMID 1744849.
Kotchen TA (Oktober 2011). »Historical trends and milestones in hypertension research: a model of the process of translational research«. Hypertension. 58 (4): 522–38. doi:10.1161/HYPERTENSIONAHA.111.177766. PMID 21859967.
Dustan HP; Roccella EJ; Garrison HH (september 1996). »Controlling hypertension. A research success story«. Arch. Intern. Med. 156 (17): 1926–35. doi:10.1001/archinte.156.17.1926. PMID 8823146.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Chockalingam A (Maj 2007). »Impact of World Hypertension Day«. Canadian Journal of Cardiology. 23 (7): 517–9. doi:10.1016/S0828-282X(07)70795-X. PMC 2650754. PMID 17534457.
Chockalingam A (Junij 2008). »World Hypertension Day and global awareness«. Canadian Journal of Cardiology. 24 (6): 441–4. doi:10.1016/S0828-282X(08)70617-2. PMC 2643187. PMID 18548140.
Alcocer L; Cueto L (Junij 2008). »Hypertension, a health economics perspective«. Therapeutic Advances in Cardiovascular Disease. 2 (3): 147–55. doi:10.1177/1753944708090572. PMID 19124418. Arhivirano iz prvotnega spletišča dne 4. decembra 2012. Pridobljeno 20. junija 2009.
William J. Elliott (Oktober 2003). »The Economic Impact of Hypertension«. The Journal of Clinical Hypertension. 5 (4): 3–13. doi:10.1111/j.1524-6175.2003.02463.x. PMID 12826765.
Coca A (2008). »Economic benefits of treating high-risk hypertension with angiotensin II receptor antagonists (blockers)«. Clinical Drug Investigation. 28 (4): 211–20. doi:10.2165/00044011-200828040-00002. PMID 18345711.

ncbi.nlm.nih.gov

Zubcevic J; Waki H; Raizada MK; Paton JF (Junij 2011). »Autonomic-immune-vascular interaction: an emerging concept for neurogenic hypertension«. Hypertension. 57 (6): 1026–33. doi:10.1161/HYPERTENSIONAHA.111.169748. PMC 3105900. PMID 21536990.
Ehret GB; Munroe PB; Rice KM; in sod. (Oktober 2011). »Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk«. Nature. 478 (7367): 103–9. doi:10.1038/nature10405. PMC 3340926. PMID 21909115.
Marshall, IJ; Wolfe, CD; McKevitt, C (9. julij 2012). »Lay perspectives on hypertension and drug adherence: systematic review of qualitative research«. BMJ (Clinical research ed.). 345: e3953. PMC 3392078. PMID 22777025.
Navar LG (december 2010). »Counterpoint: Activation of the intrarenal renin-angiotensin system is the dominant contributor to systemic hypertension«. J. Appl. Physiol. 109 (6): 1998–2000, discussion 2015. doi:10.1152/japplphysiol.00182.2010a. PMC 3006411. PMID 21148349.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Versari D; Daghini E; Virdis A; Ghiadoni L; Taddei S (Junij 2009). »Endothelium-dependent contractions and endothelial dysfunction in human hypertension«. Br. J. Pharmacol. 157 (4): 527–36. doi:10.1111/j.1476-5381.2009.00240.x. PMC 2707964. PMID 19630832.
Padwal RS; Hemmelgarn BR; Khan NA; in sod. (Maj 2009). »The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 – blood pressure measurement, diagnosis and assessment of risk«. Canadian Journal of Cardiology. 25 (5): 279–86. doi:10.1016/S0828-282X(09)70491-X. PMC 2707176. PMID 19417858.
Padwal RJ; Hemmelgarn BR; Khan NA; in sod. (Junij 2008). »The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 – blood pressure measurement, diagnosis and assessment of risk«. Canadian Journal of Cardiology. 24 (6): 455–63. doi:10.1016/S0828-282X(08)70619-6. PMC 2643189. PMID 18548142.
Padwal RS; Hemmelgarn BR; McAlister FA; in sod. (Maj 2007). »The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 – blood pressure measurement, diagnosis and assessment of risk«. Canadian Journal of Cardiology. 23 (7): 529–38. doi:10.1016/S0828-282X(07)70797-3. PMC 2650756. PMID 17534459.
Hemmelgarn BR; McAlister FA; Grover S; in sod. (Maj 2006). »The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I – Blood pressure measurement, diagnosis and assessment of risk«. Canadian Journal of Cardiology. 22 (7): 573–81. doi:10.1016/S0828-282X(06)70279-3. PMC 2560864. PMID 16755312.
Klarenbach, SW; McAlister, FA; Johansen, H; Tu, K; Hazel, M; Walker, R; Zarnke, KB; Campbell, NR; Canadian Hypertension Education Program (Maj 2010). »Identification of factors driving differences in cost effectiveness of first-line pharmacological therapy for uncomplicated hypertension«. The Canadian journal of cardiology. 26 (5): e158–63. doi:10.1016/S0828-282X(10)70383-4. PMC 2886561. PMID 20485695.
Falkner B (Maj 2009). »Hypertension in children and adolescents: epidemiology and natural history«. Pediatr. Nephrol. 25 (7): 1219–24. doi:10.1007/s00467-009-1200-3. PMC 2874036. PMID 19421783.
Esunge PM (Oktober 1991). »From blood pressure to hypertension: the history of research«. J R Soc Med. 84 (10): 621. PMC 1295564. PMID 1744849.
Chockalingam A (Maj 2007). »Impact of World Hypertension Day«. Canadian Journal of Cardiology. 23 (7): 517–9. doi:10.1016/S0828-282X(07)70795-X. PMC 2650754. PMID 17534457.
Chockalingam A (Junij 2008). »World Hypertension Day and global awareness«. Canadian Journal of Cardiology. 24 (6): 441–4. doi:10.1016/S0828-282X(08)70617-2. PMC 2643187. PMID 18548140.

nhlbi.nih.gov

»Your Guide To Lowering Your Blood Pressure With DASH« (PDF). Pridobljeno 8. junija 2009.

nps.org.au

»NPS Prescribing Practice Review 52: Treating hypertension«. NPS Medicines Wise. 1. september 2010. Pridobljeno 5. novembra 2010.

sagepub.com

tak.sagepub.com

Alcocer L; Cueto L (Junij 2008). »Hypertension, a health economics perspective«. Therapeutic Advances in Cardiovascular Disease. 2 (3): 147–55. doi:10.1177/1753944708090572. PMID 19124418. Arhivirano iz prvotnega spletišča dne 4. decembra 2012. Pridobljeno 20. junija 2009.

web.archive.org

National Clinical Guideline Centre (Avgust 2011). »7 Diagnosis of Hypertension, 7.5 Link from evidence to recommendations«. Hypertension (NICE CG 127) (PDF). National Institute for Health and Clinical Excellence. str. 102. Arhivirano iz prvotnega spletišča (PDF) dne 23. julija 2013. Pridobljeno 22. decembra 2011.
North of England Hypertension Guideline Development Group (1. avgust 2004). »Frequency of measurements«. Essential hypertension (NICE CG18). National Institute for Health and Clinical Excellence. str. 53. Arhivirano iz prvotnega spletišča dne 14. julija 2012. Pridobljeno 22. decembra 2011.
Law M; Wald N; Morris J (2003). »Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy« (PDF). Health Technol Assess. 7 (31): 1–94. PMID 14604498. Arhivirano iz prvotnega spletišča (PDF) dne 4. marca 2011. Pridobljeno 16. oktobra 2013.
National Institute Clinical Excellence (Avgust 2011). »1.5 Initiating and monitoring antihypertensive drug treatment, including blood pressure targets«. GC127 Hypertension: Clinical management of primary hypertension in adults. Arhivirano iz prvotnega spletišča dne 15. maja 2013. Pridobljeno 23. decembra 2011.
»2.5.5.1 Angiotensin-converting enzyme inhibitors«. British National Formulary. Zv. No. 62. september 2011. Arhivirano iz prvotnega spletišča dne 23. decembra 2021. Pridobljeno 22. decembra 2011.{{navedi knjigo}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
»CG34 Hypertension - quick reference guide« (PDF). National Institute for Health and Clinical Excellence. 28. junij 2006. Arhivirano iz prvotnega spletišča (PDF) dne 13. marca 2009. Pridobljeno 4. marca 2009.
Luma GB; Spiotta RT (Maj 2006). »Hypertension in children and adolescents«. Am Fam Physician. 73 (9): 1558–68. PMID 16719248. Arhivirano iz prvotnega spletišča dne 26. septembra 2007. Pridobljeno 16. oktobra 2013.

webmd.com

Shaw, Gina (7. marec 2009). »Prehypertension: Early-stage High Blood Pressure«. WebMD. Pridobljeno 3. julija 2009.

who.int

»WHO Disease and injury country estimates«. World Health Organization. 2009. Pridobljeno 11. novembra 2009.
»Global health risks: mortality and burden of disease attributable to selected major risks« (PDF). World Health Organization. 2009. Pridobljeno 10. februarja 2012.

wiley.com

onlinelibrary.wiley.com

He, FJ; MacGregor, GA (2004). MacGregor, Graham A (ur.). »Effect of longer-term modest salt reduction on blood pressure«. Cochrane database of systematic reviews (Online) (3): CD004937. doi:10.1002/14651858.CD004937. PMID 15266549.